Annual Accounts Payable
$17.00 M
-$3.00 M-15.00%
31 December 2023
Summary:
Arcus Biosciences annual accounts payable is currently $17.00 million, with the most recent change of -$3.00 million (-15.00%) on 31 December 2023. During the last 3 years, it has risen by +$1.32 million (+8.40%). RCUS annual accounts payable is now -15.00% below its all-time high of $20.00 million, reached on 31 December 2022.RCUS Accounts Payable Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly Accounts Payable
$13.00 M
-$2.00 M-13.33%
30 September 2024
Summary:
Arcus Biosciences quarterly accounts payable is currently $13.00 million, with the most recent change of -$2.00 million (-13.33%) on 30 September 2024. Over the past year, it has dropped by -$4.00 million (-23.53%). RCUS quarterly accounts payable is now -53.57% below its all-time high of $28.00 million, reached on 31 March 2023.RCUS Quarterly Accounts Payable Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
RCUS Accounts Payable Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | -15.0% | -23.5% |
| 3 y3 years | +8.4% | -1.7% |
| 5 y5 years | +448.0% | +347.5% |
RCUS Accounts Payable High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3 years | -15.0% | +70.0% | -53.6% | +30.0% |
| 5 y | 5 years | -15.0% | +448.0% | -53.6% | +435.9% |
| alltime | all time | -15.0% | +448.0% | -53.6% | +516.4% |
Arcus Biosciences Accounts Payable History
| Date | Annual | Quarterly |
|---|---|---|
| Sept 2024 | - | $13.00 M(-13.3%) |
| June 2024 | - | $15.00 M(-6.3%) |
| Mar 2024 | - | $16.00 M(-5.9%) |
| Dec 2023 | $17.00 M(-15.0%) | $17.00 M(0.0%) |
| Sept 2023 | - | $17.00 M(+41.7%) |
| June 2023 | - | $12.00 M(-57.1%) |
| Mar 2023 | - | $28.00 M(+40.0%) |
| Dec 2022 | $20.00 M(+100.0%) | $20.00 M(+89.6%) |
| Sept 2022 | - | $10.55 M(-52.0%) |
| June 2022 | - | $21.98 M(+21.5%) |
| Mar 2022 | - | $18.09 M(+80.9%) |
| Dec 2021 | $10.00 M | $10.00 M(-24.4%) |
| Sept 2021 | - | $13.22 M(-22.0%) |
| June 2021 | - | $16.96 M(-30.9%) |
| Date | Annual | Quarterly |
|---|---|---|
| Mar 2021 | - | $24.54 M(+56.5%) |
| Dec 2020 | $15.68 M(+233.4%) | $15.68 M(+93.6%) |
| Sept 2020 | - | $8.10 M(-32.8%) |
| June 2020 | - | $12.05 M(+396.8%) |
| Mar 2020 | - | $2.43 M(-48.4%) |
| Dec 2019 | $4.70 M(+51.6%) | $4.70 M(+61.9%) |
| Sept 2019 | - | $2.90 M(+18.7%) |
| June 2019 | - | $2.45 M(-13.5%) |
| Mar 2019 | - | $2.83 M(-8.8%) |
| Dec 2018 | $3.10 M(-18.8%) | $3.10 M(+47.1%) |
| Sept 2018 | - | $2.11 M(-60.9%) |
| June 2018 | - | $5.39 M(+37.4%) |
| Mar 2018 | - | $3.92 M(+2.6%) |
| Dec 2017 | $3.82 M(-1.2%) | $3.82 M |
| Dec 2016 | $3.87 M | - |
FAQ
- What is Arcus Biosciences annual accounts payable?
- What is the all time high annual accounts payable for Arcus Biosciences?
- What is Arcus Biosciences annual accounts payable year-on-year change?
- What is Arcus Biosciences quarterly accounts payable?
- What is the all time high quarterly accounts payable for Arcus Biosciences?
- What is Arcus Biosciences quarterly accounts payable year-on-year change?
What is Arcus Biosciences annual accounts payable?
The current annual accounts payable of RCUS is $17.00 M
What is the all time high annual accounts payable for Arcus Biosciences?
Arcus Biosciences all-time high annual accounts payable is $20.00 M
What is Arcus Biosciences annual accounts payable year-on-year change?
Over the past year, RCUS annual accounts payable has changed by -$3.00 M (-15.00%)
What is Arcus Biosciences quarterly accounts payable?
The current quarterly accounts payable of RCUS is $13.00 M
What is the all time high quarterly accounts payable for Arcus Biosciences?
Arcus Biosciences all-time high quarterly accounts payable is $28.00 M
What is Arcus Biosciences quarterly accounts payable year-on-year change?
Over the past year, RCUS quarterly accounts payable has changed by -$4.00 M (-23.53%)